Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | TTR | P02766 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29467223 | 1.00 | KDM4E (0.36) | KDM4ECYP3A4CYP2C19HIF1AESR1 | |
| SCHEMBL810147 | 0.84 | KDM4E (0.33) | KDM4ECYP3A4CYP2C19HIF1ATTR | |
| SCHEMBL1264062 | 0.82 | TRPA1 (0.39) | KDM4EESR1ESR2ALDH1A1 | |
| SCHEMBL17892818 | 0.80 | ALDH1A1 (0.47) | KDM4ECYP3A4ALDH1A1 | |
| SCHEMBL28987609 | 0.80 | ALDH1A1 (0.43) | KDM4ECYP3A4CYP2C19HIF1AALDH1A1 | |
| SCHEMBL31484571 | 0.80 | HSD17B10 (0.40) | ESR1ESR2 | |
| SCHEMBL9156124 | 0.80 | HRH3 (0.34) | ESR1ESR2 | |
| SCHEMBL31670525 | 0.78 | SKP2 (0.42) | CYP3A4CYP2C19 | |
| SCHEMBL1264548 | 0.78 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL809726 | 0.78 | ALDH1A1 (0.45) | KDM4ECYP3A4CYP2C19HIF1ATTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017116272-A1 | METHOD FOR PREPARING TERTIARY AMINES COMPRISING ETHYNYLBENZYL SUBSTITUENTS | PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (RU) | 2017-07-06 | — | — | WO | claimed |
| EP-3983418-B1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-11-05 | — | — | EP | disclosed |
| CN-113939522-B | Organosilane, ionic organosilane, film composition and film | 3M创新有限公司 | 2024-12-17 | — | — | CN | disclosed |
| US-12122797-B2 | Organosilane, ionic organosilane, membrane composition, and membrane | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-10-22 | — | — | US | disclosed |
| US-20220251120-A1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | US DEPARTMENT OF ENERGY | 2022-08-11 | — | — | US | disclosed |
| EP-3983418-A1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | 3M Innovative Properties Company (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-113939522-A | Organosilane, ionic organosilane, film composition and film | 3M创新有限公司 | 2022-01-14 | — | — | CN | disclosed |
| WO-2020254930-A1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-12-24 | — | — | WO | disclosed |
| US-9896551-B2 | Phosphaphenanthrene-based compound and related preparation method and application | Elite Electronic Material(Zhongshan) Co., Ltd. (CN) | 2018-02-20 | — | — | US | disclosed |
| WO-2017116272-A1 | METHOD FOR PREPARING TERTIARY AMINES COMPRISING ETHYNYLBENZYL SUBSTITUENTS | PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (RU) | 2017-07-06 | — | — | WO | disclosed |
| US-20170022228-A1 | PHOSPHAPHENANTHRENE-BASED COMPOUND AND RELATED PREPARATION METHOD AND APPLICATION | Elite Electronic Material(Zhongshan) Co., Ltd. (CN) | 2017-01-26 | — | — | US | disclosed |
| WO-2012015977-A3 | HIGHLY PORTABLE AND STABLE WORK STATION | HERSCHLER MATTHEW B (US) | 2012-05-10 | — | — | WO | disclosed |
| EP-2192645-B1 | SEPARATION MEMBRANE FOR DIRECT LIQUID FUEL CELL AND METHOD FOR PRODUCING THE SAME | TOKUYAMA CORP (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110250525-A1 | SEPARATION MEMBRANE FOR DIRECT LIQUID FUEL CELL AND METHOD FOR PRODUCING THE SAME | TOKUYAMA CORPORATION (JP) | 2011-10-13 | — | — | US | disclosed |
| EP-2192645-A1 | SEPARATION MEMBRANE FOR DIRECT LIQUID FUEL CELL AND METHOD FOR PRODUCING THE SAME | Tokuyama Corporation (JP) | 2010-06-02 | — | — | EP | disclosed |
| US-5138001-A | Optical disc substrates; low birefringence, heat and moisture absorption resistance, high transparency | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1992-08-11 | — | — | US | disclosed |
| EP-0415729-A2 | Vinylphenyl compound, process for the production thereof, polymerizable composition containing same, and crosslinked polymer formed therefrom | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1991-03-06 | — | — | EP | disclosed |
| US-4680342-A | Flame resistant alkenyl aromatic compounds and polymers containing chemically bonded phosphorus and blends with polyphenylene ether | GENERAL ELECTRIC COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| EP-0147724-A2 | Flame resistant alkenyl aromatic compounds and polymers containing chemically bonded phosphorus and blends with polyphenylene ether | GENERAL ELECTRIC COMPANY (US) | 1985-07-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251120-A1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | PHOSPHO1, ARRB1, OR51E2 | KDM4E 2873/4885CYP3A4 2878/4885CYP2C19 2682/4885 |
| US-20170022228-A1 | PHOSPHAPHENANTHRENE-BASED COMPOUND AND RELATED PREPARATION METHOD AND APPLICATION | BMI1, RPL23A, P2RY14 | KDM4E 806/4885CYP3A4 1793/4885CYP2C19 403/4885 |
| US-12122797-B2 | Organosilane, ionic organosilane, membrane composition, and membrane | PHOSPHO1, ARRB1, OR51E2 | KDM4E 2873/4885CYP3A4 2878/4885CYP2C19 2682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.